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Abstract
Between 2005 and 2007 Chikungunya virus (CHIKV) caused its largest outbreak/epidemic in documented history. An
unusual feature of this epidemic is the involvement of Ae. albopictus as a principal vector. Previously we have demonstrated
that a single mutation E1-A226V significantly changed the ability of the virus to infect and be transmitted by this vector
when expressed in the background of well characterized CHIKV strains LR2006 OPY1 and 37997. However, in the current
study we demonstrate that introduction of the E1-A226V mutation into the background of an infectious clone derived from
the Ag41855 strain (isolated in Uganda in 1982) does not significantly increase infectivity for Ae. albopictus. In order to
elucidate the genetic determinants that affect CHIKV sensitivity to the E1-A226V mutation in Ae. albopictus, the genomes of
the LR2006 OPY1 and Ag41855 strains were used for construction of chimeric viruses and viruses with a specific
combination of point mutations at selected positions. Based upon the midgut infection rates of the derived viruses in Ae.
albopictus and Ae. aegypti mosquitoes, a critical role of the mutations at positions E2-60 and E2-211 on vector infection was
revealed. The E2-G60D mutation was an important determinant of CHIKV infectivity for both Ae. albopictus and Ae. aegypti,
but only moderately modulated the effect of the E1-A226V mutation in Ae. albopictus. However, the effect of the E2-I211T
mutation with respect to mosquito infections was much more specific, strongly modifying the effect of the E1-A226V
mutation in Ae. albopictus. In contrast, CHIKV infectivity for Ae. aegypti was not influenced by the E2-1211T mutation. The
occurrence of the E2-60G and E2-211I residues among CHIKV isolates was analyzed, revealing a high prevalence of E2-211I
among strains belonging to the Eastern/Central/South African (ECSA) clade. This suggests that the E2-211I might be
important for adaptation of CHIKV to some particular conditions prevalent in areas occupied by ECSA stains. These newly
described determinants of CHIKV mosquito infectivity for Ae. albopictus and Ae. aegypti are of particular importance for
studies aimed at the investigation of the detailed mechanisms of CHIKV adaptations to its vector species.
Citation: Tsetsarkin KA, McGee CE, Volk SM, Vanlandingham DL, Weaver SC, et al. (2009) Epistatic Roles of E2 Glycoprotein Mutations in Adaption of Chikungunya
Virus to Aedes Albopictus and Ae. Aegypti Mosquitoes. PLoS ONE 4(8): e6835. doi:10.1371/journal.pone.0006835
Editor: Bradley S Schneider, Institut Pasteur, France
Received June 15, 2009; Accepted July 23, 2009; Published August 31, 2009
Copyright:  2009 Tsetsarkin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: K. A. Tsetsarkin was supported by a McLaughlin Predoctoral Fellowship. D.L. Vanlandingham was supported in part by NIH T32 A107536. This study was
supported in part by funding from the NIH 1 R21 AI073389. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kotsetsa@utmb.edu
Introduction
The recent massive epidemics of Chikungunya virus (CHIKV)
in Africa, the Indian Ocean islands, India, and the small outbreak
in Europe have elevated this arthropod-borne virus (arbovirus) to
the status of a major global health problem [1]. CHIKV, a
member of the Alphavirus genus in family Togaviridae, is transmitted
to humans by Aedes (Stegomyia) spp mosquitoes, primarily Ae. aegypti.
However, transmission by a previously unrecognized vector
species, Ae. albopictus, has been a critical contributor facilitating
recent epidemics [2–8].
Phylogenetic analysis of CHIKV strains obtained during
outbreaks circulating in Ae. albopictus-human transmission cycles
have identified the independent acquisition of a common
mutation, namely E1-A226V, in strains isolated from different
geographic regions [2,5], suggesting that this mutation is
associated with specific genetic adaptations to Ae. albopictus
mosquitoes. Recently we demonstrated that the E1-A226V
mutation significantly increases the ability of CHIKV to infect
and be transmitted by a laboratory colony of Ae. albopictus
mosquitoes when expressed in the background of the well-
characterized La Reunion LR2006 OPY1 and West-African
37997 CHIKV strains [9]. Furthermore, CHIKV isolates from
Reunion Island possessing valine at position E1-226 disseminate
significantly more efficiently to the salivary glands of Ae. albopictus
mosquitoes collected from La Reunion Island and Mayotte, as
compared with CHIKV isolates bearing alanine at this position
[10]. Taken together, these findings provide compelling evidence
that the E1-A226V mutation is a major genetic determinant of
adaptation of CHIKV to a new vector species, Ae. albopictus, and
provides a plausible explanation for how this mutant CHIKV
caused an epidemic in a region lacking the more typical urban
vector, Ae. aegypti.
Alphaviruses are enveloped single-stranded positive-sense RNA
viruses. Genomic RNA, of ,12,000 nt, consists of two open
reading frames (ORF): the first, translated from genomic RNA,
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second ORF is translated from sub-genomic RNA to produce the
three main structural proteins (capsid, E2 and E1). The E2 and E1
envelope glycoproteins form heterodimers on the viral surface,
where E2 lies mainly on top of E1 and is believed to interact with
cellular receptors [11]. Following binding and endocytosis, the E1
underlying E2 mediates fusion of viral and cellular membranes
within the acidic conditions of endosomal compartments [12].
Ae. albopictus mosquitoes are native to Southeast Asia, but have
recently spread globally due to the advent of modern shipment,
with the current geographic range including Europe, Africa, the
Middle East, North and South America and the Caribbean
[13,14]. As a consequence of this recent range expansion, the
pathogens transmitted by this species may be introduced or
reemerge in new areas. This scenario was exemplified in August
and September of 2007, when the CHIKV–Ae. albopictus
transmission cycle was established for the first time in Europe,
with an estimated 254 human cases in Italy [4,6,15,16]. Besides
CHIKV and dengue virus, Ae. albopictus has been demonstrated to
be susceptible to infection by several clinically important
arboviruses including; eastern [17,18], and Venezuelan equine
encephalitis (VEEV) [19,20], yellow fever [21], West Nile [22–24],
Japanese encephalitis [25], and Rift Valley fever viruses [26],
among others. Understanding the mechanism(s) responsible for
adaptation of arboviruses to a new vector may enhance our ability
to predict spatial and temporal epidemic risks, and to direct vector
control efforts towards specific arthropods, and so will enhance our
ability to reduce the incidence of these diseases.
Previous investigations of the effects of the E1-A226V mutation
on CHIKV infection of midguts, dissemination into salivary
glands, and transmission to a vertebrate host by Ae. albopictus
suggested that the epidemiologic success of CHIKV with the E1-
A226V mutation was most likely due to enhanced midgut
infectivity [9,10]. The ability of CHIKV with A or V residues in
position E1-226 to disseminate to salivary glands and be
transmitted to suckling mice by orally infected and intrathorac-
ically injected Ae. albopictus was also compared. When intratho-
racically injected into the mosquito hemocoel, CHIKV does not
need to infect midgut cells and can directly infect secondary organs
including the salivary glands. Since in intrathoracically infected Ae.
albopictus the E1-A226V mutation did not enhance dissemination/
transmission rates (Higgs lab unpublished data), it was thus
concluded that the effect of this mutation occurs before virus is
released from the midgut into the hemocoel. These data, together
with previous findings [9,10], support the hypothesis that
increased Ae. albopictus midgut infectivity resulting from the
A226V mutation plays a primary role in enhanced viral
transmission.
Little is known about the molecular mechanisms responsible for
the selective advantage associated with the E1-A226V mutation.
Earlier we demonstrated that the E1-A226V mutation was
responsible for modulation of the CHIKV cholesterol dependence
for replication in C6/36 cells, suggesting that specific lipid
composition of the endosomal compartments of Ae. albopictus
midgut cells might provide an advantage for fusion to CHIKV
with the E1-A226V mutation [9]. However, the majority of the
previously described determinants of vector specificity of different
alphaviruses are located within the E2 glycoprotein, circumstan-
tially indicating that the process of alphavirus adaptation to new
mosquito species occurs via adaptation to a specific cell surface
receptor expressed in this mosquito [27–31]. Here, we character-
ize mutations in the E2 protein that differentially affect Ae.
albopictus CHIKV midgut infectivity based on the presence of E1-
226A or E1-226V residues. Based on our data we conclude that a
mutation at position E2-60 influences CHIKV infectivity for Ae.
albopictus, regardless of the mutations in position E1-226, and also
modulates CHIKV infectivity for Ae. aegypti. Furthermore,
substitutions at E2-211 are crucial for CHIKV sensitivity to the
E1-226V mutation in Ae. albopictus mosquitoes, but have no effect
on CHIKV infectivity for Ae. aegypti, and are widely dispersed
among CHIKV isolates. These findings provide greater insight
into the complexity of the molecular mechanisms involved in
adaptation of CHIKV to a new vector.
Results
Introduction of the E1-A226V mutation into the
backbone of the Ag41855 strain of CHIKV does not lead
to a significant increase in infectivity for Ae. albopictus
mosquitoes
Previously we demonstrated that the introduction of the single
amino acid substitution E1-A226V significantly increases CHIKV
infectivity for midguts of Ae. albopictus mosquitoes [9]. To further
investigate the effect of this mutation on infectivity of different
strains of CHIKV for Ae. albopictus, the E1-A226V mutation was
introduced into an enhanced green fluorescent protein (eGFP)
expressing infectious clones (i.c.) of the Ag41855 strain of CHIKV
(designated as p41855-GFP-226A). The resultant clone was
designated p41855-GFP-226V (supplemental data Fig. S1). The
specific infectivity values after electroporation of the RNAs
produced from p41855-GFP-226A and p41855-GFP-226V were
similar - approximately 10
6 pfu/mg of RNA (supplemental data
Table S1), with no detectable differences in plaque sizes. Both
constructs provided similar viral titers following in vitro transcribed
RNA transfection into BHK-21 cells on 1 and 2 days post-
electroporation (dpe), indicating that introduction of the E1-
A226V mutation into the Ag41855 strain therefore does not
attenuate this virus in BHK-21 cells (supplemental data Table S1).
The relative infectivity of 41855-GFP-226V and 41855-GFP-
226A viruses in Ae. albopictus mosquitoes was determined by oral
exposure to serial 10-fold viral dilutions. In two independent
experiments the oral infectivities of 41855-GFP-226V and 41855-
GFP-E1-226A viruses were not significantly different (p.0.05).
This demonstrates that for the Ag41855 strain, the E1-A226V
mutation does not affect Ae. albopictus midgut infectivity (Table 1).
The mean OID50 values for 41855-GFP-226V and 41855-GFP-
226A were 6.33 and 6.88 Log10TCID50/ml respectively (Table 1),
which was significantly higher compared to OID50 values of
previously characterized CHIKV strains LR2006 OPY1 and
37997 with either alanine or valine at position E1-226 [9],
suggesting that the Ag41855 strain is significantly more attenuated
for Ae. albopictus infection when compared with the LR2006 OPY1
and 37997 strains.
The sequence of 41855-GFP-226A was identical to that of the
virus stock used for i.c. construction and we previously showed that
introduction of the eGFP gene into backbone of LR2006 OPY1
and 37997 strains of CHIKV does not significantly affect
infectivity for Ae. albopictus and Ae. aegypti mosquitoes [32,33]
Tsetsarkin unpublished data]. Nevertheless, we wanted to
determine whether or not the attenuation observed for 41855-
GFP-226V and 41855-GFP-226A in Ae. albopictus could reflect
artifacts of the i.c. construction, for example introduction of the
eGFP gene under control of an additional sub-genomic promoter
or incompatibility of viral segments that were combined in the
clone-derived virus but that coexist separately as quasispecies in
the viral population. We compared infectivity of the stock
Ag41855 virus with that of the viruses produced from the
Ag41855 and p41855-GFP-226A clones (Table 2, supplemental
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significantly different (p.0.1) indicating that virus produced from
the full-length and eGFP-expressing i.c. retained the infection
phenotype of the parental virus in Ae. albopictus. This also indicates
that the lower infectivity observed for 41855-GFP-226A and
41855-GFP-226V for Ae. albopictus, as compared with viruses
produced from the i.c. of the LR2006 OPY1 and 37997 strains, is
attributed to the specific mutation(s) in the genome of Ag41855
strain.
Sequence comparison of Ag41855, LR2006 OPY1 and
37997 strains
Several recent phylogenetic analyses of CHIKV have grouped
the Ag41855 and LR2006 OPY1 strains into the East/Central/
South African phylogroup [34,35] suggesting a close evolutionary
relationship. The 37997 strain is a member of the West African
phylogroup, which is the outlier among CHIKV strains. Strain
37997 was therefore used as a reference control to identify
positions in the Ag41855 genome responsible for attenuation in Ae.
albopictus, and to determine the sites affecting sensitivity to the E1-
A226V mutation in Ae. albopictus.
Sequence comparison of the Ag41855 and LR2006 OPY1
strains revealed a total of 202 nucleotide differences (1.7%),
encoding 31 amino acid substitutions: 18 in the non-structural and
13 in the structural coding sequence (Table 3). The nucleotide
sequence of 37997 differed from Ag41855 and LR2006 OPY1 by
14.7%.
A comparison of amino acid sequences for strains Ag41855,
LR2006 OPY1 and 37997 (Table 3) identified eight positions that
are unique in Ag41855, but are the same in both the LR2006
OPY1 and 37997 strains: three in nsP3 protein (positions 328, 358,
and 461), three in the E2 protein (positions 60, 162, and 211) and
two in E1 (positions 19 and 377). These data suggest that the
unique Ag41855 amino acids could modulate CHIKV infectivity
for Ae. albopictus. Since numerous previous studies identified the E2
protein as a major determinant of mosquito infectivity for different
alphaviruses including Sindbis virus (SINV) and VEEV [27–31]
we first decided to investigate if the mutations at E2 positions 60,
162, and 211 were responsible for the observed attenuation of the
Ag41855 strain, and how these mutations related to the
insensitivity of this strain to the E1-A226V mutation in Ae.
albopictus.
Determinants of attenuation of Ag41855 strain in Ae.
albopictus mosquitoes
To elucidate genetic determinants of low mosquito infectivity of
strain Ag41855, the fragment of 8021-9225 nt. (which corresponds
to 152–553 aa. in the structural polypeptide) from the LR2006
OPY1 i.c. containing the E2 60D, 162A, and 211T mutations, was
introduced into 41855-GFP-226V (supplemental data Fig. S1).
Based on specific infectivity and replication data, the chimeric
virus 41855/LR-GFP-226V was not attenuated in BHK-21 cells
(supplemental data Table S1), indicating that this genome region is
interchangeable between the LR2006 OPY1 and Ag41855 strains.
The 41855/LR-GFP-226V virus was ,1000 times more infectious
for Ae. albopictus as compared to Ag41855-GFP-226V virus
(OID50=3.78) (Table 4). The reverse chimera LR/41855-GFP-
226V containing the 8021-9225 nt fragment of Ag41855 in the
backbone of LR-GFP-226V, demonstrated an OID50 value similar
to that observed for Ag41855-GFP-226V (OID50=6.33), indicat-
ing that this region encodes the major determinant(s) for Ae.
albopictus midgut infectivity in the Ag41855 strain. Additionally,
these data indicate that mutations in the nsP3 and E1 genes of
Table 1. Effect of the E1-A226V mutation on infectivity of different strains of CHIKV to Ae. albopictus mosquitoes.
Backbone Exp E1-226 N m OID50 (C95)O I D 50 mean p
41855-GFP 1 V 67 6.27 (5.82–6.61) 6.33 p.0.05
2 54 6.38 (5.94–6.74)
1 A 78 6.96 (6.57–7.31) 6.88
2 53 6.79 (6.40–7.32)
LR-GFP Comb V 261 NG 3.52 p,0.01
Comb A 194 NG 5.45
37997-GFP Comb V 260 NG 3.16 p,0.01
Comb A 274 NG 5.10
Exp – experiment number.
E1-226 – amino acid at position E1-226.
N m – number of mosquitoes used to estimate OID50 value.
OID50 (C95) – oral infectious dose 50 and 95% confidence intervals are expressed as Log10TCID50/ml.
OID50 values and confidence intervals were calculated using PriProbit (Version 1.63).
p – comparison of statistical significance of difference in OID50 values between viruses with E1-226A and E1-226V mutations.
Comb – combined summary of two independent experiments published earlier [9].
NG – value is not given.
doi:10.1371/journal.pone.0006835.t001
Table 2. Comparison of oral infectivity of the parental virus
(Ag41855) and viruses produced from full-length (Ag41855 ic)
and eGFP expressing (41855-GFP-226A) i.c. of Ag41855 strain
in Ae. albopictus mosquitoes.
Virus N m OID50 C95 p
Ag41855 67 6.74 6.39–7.17 p.0.1
Ag41855 ic 78 6.40 6.06–6.85
41855-GFP-226A 131 6.88
a NG
N m – number of mosquitoes used to estimate OID50 value.
OID50 and 95% confidence intervals are expressed as Log10TCID50/ml.
a– average of two independent experiments.
NG – value is not given.
doi:10.1371/journal.pone.0006835.t002
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mosquito infectivity phenotype. They therefore were excluded
from further analysis.
To further investigate the effect of the 8021–9225 region on
CHIKV mosquito infectivity in the background of alanine at E1-
226, the 8021-9225 fragment from LR2006 OPY1 was introduced
into the 41855-GFP-226A virus (supplemental data Fig. S1). The
OID50 for the resultant chimeric virus 41855/LR-GFP-226A was
5.21 Log10TCID50/ml (Table 4) - not significantly different to the
OID50 values for LR-GFP-226A virus [9]. Importantly, introduc-
tion of the 8021–9225 genome fragment of LR2006 OPY1 strain
into the background of Ag41855 completely restored the
enhancing effect of the E1-A226V mutation on infectivity for Ae.
albopictus to the levels reported for genetic backgrounds of strains
LR2006 OPY1 and 37997 [9].
Individual role of the mutations at positions E2 60, 162,
and 211 on CHIKV infectivity for Ae. albopictus
mosquitoes
To further characterize the roles of each of the E2 mutations on
CHIKV infectivity for Ae. albopictus, point mutations encoding
amino acids from the LR2006 OPY1 strain were introduced into
the backbone of 41855-GFP-226V and 41855-GFP-226A i.c.,
either individually or in combination (Table 4 and supplemental
data Fig. S1). Specific infectivity of in vitro transcribed RNA,
plaque size and viral titers produced at 1 and 2 dpe were
determined for each of the constructs (supplemental data Table
S1). All of the constructs were indistinguishable by these
parameters, indicating that these mutations do not cause
intermolecular incompatibility with the rest of the viral genome
and that the resultant viruses are suitable for testing in the Ae.
albopictus.
Individual introduction of the mutations E2-G60D and E2-
I211T into 41855-GFP-226V was responsible for a significant
increase of viral infectivity for Ae. albopictus to similar levels (OID50
values: 5.51 and 5.40 respectively). The OID50 of 41855-GFP-
226V with the E2-V162A mutation was not significantly different
from the OID50 for the 41855-GFP-226V virus (Table 4). This
suggests that E2-V162A likely plays no role in CHIKV infectivity
for Ae. albopictus. Interestingly, introduction of each of the three
mutations individually did not lead to increase in viral infectivity to
the level observed for the triple mutant 41855/LR-GFP-226V,
indicating that combinations of at least two mutations are
apparently required for the high infectivity phenotype.
Analysis of Ae. albopictus midgut infectivity for 41855-GFP-226V,
in which two substitutions were introduced into the E2 protein,
revealed that a combination of the G60D and I211T mutations is
necessary and sufficient to completely restore infectivity of the
Ag41855 strain to the same levels as that observed for 41855/LR-
GFP-226V and LR-GFP-226V viruses (p.0.1) (Table 4). The Ae.
albopictus infectivity of viruses where the E2-V162A mutation was
combined with either the E2-G60D or E2-I211T mutations, was
indistinguishable from the infectivity of the 41855-GFP-226V
virus that contained the single mutations in E2-G60D and E2-
I211T. This observation further supports the conclusion that
position E2-162 does not affect CHIKV infectivity for Ae.
albopictus. Altogether, these results indicate that there is a strong
synergistic effect of the E2-G60D and E2-I211T mutations on
CHIKV infectivity for Ae. albopictus, when expressed in combina-
tion with valine at position E1-226.
To further evaluate the relationships between these different
mutations, four additional viruses were constructed in which single
and double substitutions at positions E2-60, E2-161 and E2-211
from the Ag41855 strain were substituted into the backbone of
LR-GFP-226V (Table 4). The OID50 values for LR-GFP-226V
with individual mutations E2-D60G and E2-T211I were indistin-
guishable as compared to OID50 values of the 41855-GFP-226V
virus with E2-G60D and E2-I211T mutations expressed individ-
ually or in combination with E2-A162V, but were significantly
higher as compared with LR-GFP-226V. The OID50 value for
LR-GFP-226V with both the E2-D60G and E2-T211I mutations
was indistinguishable from the OID50 values of 41855-GFP-226V
or chimeric virus LR/41855-GFP-226V (p.0.1). These data
suggest that the specific phenotype(s) associated with the E2
mutations introduced into strain Ag41855 would be retained if
these mutations were expressed in other CHIKV strains.
The genome region of the LR2006 OPY1 strain that contained
mutations at positions E2-60, E2-162 and E2-211 was also
responsible for a significant increase in Ae. albopictus midgut
infectivity for the 41855-GFP-226A virus. In this regard it was





nsP1 326 M V M 326
a
391 L F L 391
a
488 Q R K 488
a
nsP2 54 S N S 589
a
793 A V A 1328
a
nsP3 31 D G D 1364
a
217 Y H Y 1550
a
328 PQ Q 1661
a
337 T I T 1670
a
358 PS S 1691
a
435 R C H 1768
a
438 A V V 1771
a
449 T M A 1782
a
461 LP P 1794
a
471 P S P 1804
a
524 Stop R Stop 1857
a
nsP4 75 T A T 1938
a
254 T A T 2117
a
E2 60 GD D 385
b
162 VA A 487
b
211 IT T 536
b
312 T M T 637
b
318 M V T 643
b
375 S T S 700
b
377 V I V 702
b
386 V A V 711
b
K6 8 V I A 756
b
E1 19 IV V 828
b
226 A V A 1035
b
284 D E D 1093
b
377 TA A 1186
b
a– position in the non-structural polypeptide.
b– position in the structural polypeptide.
Bold type indicates the positions which are the same in LR2006 OPY1 and
37997 strains but different in Ag41855 strain.
doi:10.1371/journal.pone.0006835.t003
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mutations in the 41855-GFP-226A virus, and to determine how
these roles correlated with the effects of these mutations in the
41855-GFP-226V virus. In contrast to the 41855-GFP-226V virus,
the introduction of the single mutation E2-G60D into 41855-GFP-
226A almost completely restored viral infectivity phenotype to the
relatively high levels observed for 41855/LR-GFP-226A and LR-
GFP-226A (p.0.1) (Table 4, 1). However, the E2-I211T mutation
led to no apparent effect on CHIKV infectivity for Ae. albopictus.
Analysis of the viruses bearing double mutants in the E2 protein
revealed a similar result: viruses containing E2-G60D were
significantly more infectious for Ae. albopictus than the 41855-
GFP-226A virus regardless of the second mutations at positions
E2-162 and E2-211. The combination of E2-A162V and E2-
I211T did not affect the viral infectivity phenotype as compared to
41855-GFP-226A. In the backbone of 41855-GFP-226A, the E2-
G60D and E2-I211T mutations had a disproportionate effect on
the CHIKV mosquito infectivity phenotype; where E2-G60D
exerted the major effect whilst E2-I211T was responsible for only
a marginal effect.
Ag41855 strain of CHIKV is attenuated in Ae. aegypti
mosquitoes
Prior to the 2006–2007 outbreaks, Ae. aegypti was the principal
vector responsible for most urban epidemics of chikungunya [36].
Previouslywe showed that, in contrastto the situation forAe. albopictus
mosquitoes, the E1-A226V mutation does not increase infectivity for
Ae.aegypti when expressed in the backbones of the LR2006 OPY1 and
37997 strains of CHIKV [9]. Therefore, the unusual phenotype of
the Ag41855 strain in Ae.albopictus mosquitoes led us to investigate the
mosquito infectivity phenotype of this strain in Ae. aegypti.
The OID50 values of 41855-GFP-226A in Ae. aegypti were 6.92
and 7.24 Log10TCID50/ml, which are significantly higher than the
OID50 values determined previously for LR-GFP-226A and 37997-
GFP-226A viruses (p,0.01) (Table 5). Mosquito infectivity of the
41855-GFP-226V was significantly lower than that of the LR-GFP-
226V and 37997-GFP-226V viruses, indicating that the Ag41855
strain of CHIKV is also attenuated in its ability to infect Ae. aegypti.
Interestingly, 41855-GFP-226A was slightly more infectious for Ae.
aegypti than 41855-GFP-226V (p1,0.05 for the first experiment and
p2.0.05 for the second). This finding corroborated our previous
Table 4. Effect of mutations in E2 proteins on CHIKV infectivity for Ae. albopictus mosquitoes.
Backbone Clone name E1-226 E2-60 E2-162 E2-211 Exp N m OID50 (C95)O I D 50 mean
41855-GFP 41855-GFP-226V V GVI Comb 121 NG 6.33
NG D VI 1 83 5.51 (5.13–6.13) 5.51
NG G A I 1 99 6.85 (6.18–9.64) 6.85
NG GVT 1 125 5.40 (4.94–5.77) 5.40
NG G AT1 83 5.57 (5.27–5.83) 5.57
NG D V T 1 153 3.36 (3.01–3.60) 3.50
2 105 3.64 (3.31–3.85)
NG DAI 1 115 5.52 (5.27–5.80) 5.52
41855/LR-GFP-226V DAT1 107 3.78 (2.91–4.08) 3.65
2 102 3.52 (3.19–3.80)
41855-GFP-226A A GVI Comb 131 NG 6.88
NG D VI 1 133 5.69 (5.42–5.92) 5.74
2 79 5.79 (5.48–6.09)
NG G A I 1 75 6.71 (6.44–6.99) 6.71
NG GVT 1 123 6.51 (6.24–6.78) 6.77
2 97 7.03 (6.74–7.43)
NG G AT1 98 6.97 (6.68–6.31) 6.97
NG D V T 1 82 5.48 (5.12–5.79) 5.48
NG DAI 1 75 5.65 (5.34–5.95) 5.65
41855/LR-GFP-226A DAT1 63 5.21 (4.89–5.55) 5.26
2 134 5.31 (4.96–5.60)
LR-GFP LR/41855-GFP-226V V GVI 1 135 6.40 (5.98–7.28) 6.40
NG G AT1 41 5.38 (5.00–5.91) 5.38
NG DAI 1 120 5.24 (4.92–5.54) 5.24
NG D VI 1 107 5.52 (5.27–5.80) 5.52
NG G A I 1 77 6.33 (5.97–6.92) 6.33
Exp – experiment number.
N m – number of mosquitoes used to estimate OID50 value.
OID50 (C95) – oral infectious dose 50 and 95% confidence intervals are expressed as Log10TCID50/ml.
Comb – combined summary of two independent experiments.
NG – value is not given.
Residues in bold type correspond to authentic amino acids at indicated positions of strain Ag41855. Residues in italics correspond to authentic amino acids at indicated
positions of strain LR2006 OPY1.
doi:10.1371/journal.pone.0006835.t004
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more infectious for Ae. aegypti mosquitoes [9].
Determinants of attenuation of the Ag41855 strain in Ae.
aegypti mosquitoes
To determine the genomic regions of Ag41855 that are
responsible for attenuation of Ag41855 in Ae. aegypti, the chimeric
viruses 41855/LR-GFP-226A and 41855/LR-GFP-226V as
described above, were tested. These viruses were significantly
more infectious for Ae. aegypti than 41855-GFP-226A and 41855-
GFP-226V (p,0.01), with OID50 values similar to those of
CHIKV possessing either an alanine or a valine at position E1-226
when expressed in the backbone of strains LR2006 OPY1 and
37997 (p.0.1) (Table 6). These data indicate that the 8021–9225
Table 5. Effect of the E1-A226V mutation on infectivity of different strains of CHIKV to Ae. aegypti mosquitoes.
Backbone Exp E1-226 N m OID50 (C95)O I D 50 mean p
41855-GFP 1 V 112 7.63 (7.35–8.23) 7.71 p1,0.05
2 82 7.78 (7.46–8.21) p2.0.05
1 A 77 6.92 (6.61–7.24) 7.12
2 90 7.24 (6.85–7.66)
LR-GFP Comb V 172 NG 6.52 p1,0.05
Comb A 156 NG 5.87 p2.0.05
37997-GFP Comb V 262 NG 6.47 p1,0.01
Comb A 297 NG 5.70 p2.0.05
Exp – experiment number.
E1-226 – amino acid at position E1-226.
N m – number of mosquitoes used to estimate OID50 value.
OID50 (C95) – oral infectious dose 50 and 95% confidence intervals are expressed as Log10TCID50/ml.
OID50 values and confidence intervals were calculated using PriProbit (Version 1.63).
p1 – comparison of statistical significance of difference in OID50 values between viruses with E1-226A and E1-226V mutations for experiment 1. p2 – comparison of
statistical significance of difference in OID50 values between viruses with E1-226A and E1-226V mutations for experiment 2.
Comb – combined summary of two independent experiments published earlier [9].
NG – value is not given.
doi:10.1371/journal.pone.0006835.t005
Table 6. OID50 for CHIKV in Ae. aegypti mosquitoes.
Backbone Clone name E1-226 E2-60 E2-162 E2-211 N m OID50 C95
41855-GFP 41855-GFP-226V V GVI NG 7.71
a NG
NG D VI 105 6.18 5.89–6.64
NG G A I 61 .7.30 ND
NG GVT 67 .7.52 ND
NG G AT 73 .7.31 ND
NG D V T 52 6.31 5.78–7.14
NG DAI 81 6.42 6.12–6.85
41855/LR-GFP-226V DAT 114 6.09 5.81–6.43
41855-GFP-226A A GVI NG 7.12
a NG
NG D VI 83 6.13 5.83–6.46
NG G A I 103 .7.52 ND
NG GVT 50 7.30 7.02–7.96
NG G AT 73 .7.52 ND
NG D V T 82 6.20 5.97–6.44
NG DAI 86 6.27 6.04–6.53
41855/LR-GFP-226A DAT 93 6.23 5.93–6.52
Effect of mutations in E2 proteins on CHIKV infectivity for Ae. aegypti mosquitoes.
Exp – experiment number.
N m – number of mosquitoes used to estimate OID50 value.
OID50 (C95) – oral infectious dose 50 and 95% confidence intervals are expressed as Log10TCID50/ml.
a– average of two independent experiments.
NG – value is not given.
ND – value is not determined.
Residues in bold type correspond to authentic amino acids at indicated positions of strain Ag41855. Residues in italics correspond to authentic amino acids at indicated
positions of strain LR2006 OPY1.
doi:10.1371/journal.pone.0006835.t006
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CHIKV attenuation in Ae. aegypti. Further analysis of 41855-GFP-
226A and 41855-GFP-226V with different combinations of the
single or double mutants at positions E2 60, 162, and 211 revealed
that introduction of the single mutation E2-G60D was sufficient to
increase viral infectivity of the Ag41855 strain for Ae. aegypti to the
OID50 values attributed to CHIKV strains LR2006 OPY1 and
37997 with either alanine or valine at position E1-226 (Table 5, 6).
Expression of the E2-60D mutation individually or in combination
with E2-A162V or E2-I211T led to a significant decrease in
OID50 values as compared with the values determined for the
41855-GFP-226A and 41855-GFP-226V viruses (p,0.01). In
contrast, introduction of the E2-A162V and E2-I211T mutations
individually or in combination resulted in viruses almost
indistinguishable from 41855-GFP-226A and 41855-GFP-226V
with respect to their ability to infect Ae. aegypti midguts, indicating
that these two positions do not play important roles in CHIKV
transmitted by Ae. aegypti.
Distribution of the amino acids at E2-60 and E2-211
among characterized CHIKV isolates
The effects of the E2-D60G and E2-T226I on infectivity of
CHIKV for Ae. albopictus and Ae. aegypti that we identified in
previous experiments raised an important question regarding the
origin of these particular mutations in the genome of the Ag41855
strain, and what evolutionary advantages might be associated with
them. To address these questions, we analyzed the distribution of
E2-60G and E2-226I mutations among known CHIKV isolates
(supplemental data Table S2) and correlated this distribution with
their evolution as determined using phylogenetic relationships.
The entire genome region encoding the E2-K6-E1 proteins was
sequenced or obtained from GenBank and a phylogenetic tree was
constructed by the neighbor-joining and maximum parsimony
methods followed by bootstrap analysis [37] with 1000 replicates
to determine confidence values for the groupings. The phylogeny
in Figure 1 reproduces the expected 3 major clades (West African,
Asian, and East/Central/South African (ECSA)) [38], with the
Figure 1. Distribution of the amino acids at E2-60, E2-211 and E1-226 among selected CHIKV isolates. Phylogenetic tree of CHIKV
isolates generated using a maximum parsimony algorithm on the 2772 nt. complete E2-K6-E1 genes sequence. Bootstrap analysis was performed
with 1000 replicates to determine confidence values on the clades within trees. Character evolution analyses was performed using MacClade4
program. Strains in black – contain E2-60D, E2-211T and E1-226A residues. Strains in red – contain E2-60D, E2-211I and E1-226A residues. Strains in
green – contain E2-60D, E2-211T and E1-226V residues. Strains in pink – contain E2-60G, E2-211I and E1-226A residues. Strains in blue – contain E2-
60G, E2-211T and E1-226A residues.
doi:10.1371/journal.pone.0006835.g001
Role of E2-Protein Mutations
PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6835strains from the recent outbreak evolving as a monophyletic group
from the ECSA clade [2]. A manuscript including detailed
discussion of the phylogenetic relationship of these strains is
currently in preparation (Volk, personal communication).
The E2-60G was present in only four out of 39 CHIKV strains,
with no apparent close phylogenetic relationships among them
(Fig. 1, supplemental data Table S2). MaClade character evolution
analyses indicated that the aspartic acid residue was ancestral, and
the glycine residue evolved convergently 4 times. Although no
apparent similarities were detected in the passage history of the
four strains with the glycine residue (supplemental data Table S2),
the presence of different residues in variants of the 1953 Ross
strain with different passage histories suggested that the D60G
substitution may have been selected by cell culture or animal
passage.
In contrast to E2-60G, the E2-211I had a very different
distribution among CHIKV isolates (Fig. 1). It was present in 10 of
39 strains, all belonging to the ECSA clade. Interestingly, this
residue was found to be even more prevalent in this phylogroup
among strains isolated before 2005 as compared to E2-211T.
These data suggest that the E2-211I might be important for
adaptation of CHIKV to some particular conditions prevalent in
these regions, for example specific vectors or vertebrates involved
in the sylvatic transmission cycle. Within the ECSA clade, E2-
211T was found in all isolates from the 2005–2007 CHIKV
outbreak and in two more strains isolated in 1976 from the South
African Republic (Fig. 1, supplemental data Table S2). Character
analyses indicated that the E2-I211T substitution probably
occurred convergently on three separate occasions within the
ECSA clade, leading to South African 1976 strains, Indian Ocean
2005–2007 strains and Gabonese 2007 strain (Fig. 1). This
conclusion is supported by the presence of the E2-211I residue in
two strains from Comoros isolated in 2005 [39] belonging to the
Indian Ocean clade. The sequences for these strains are
unavailable in GenBank which precluded us from including them
in our phylogenetic analysis. Finally, as determined previously
[2,5], our analyses indicated at least three convergent E1-A226V
replacements during the recent epidemics in the Indian Ocean
and India (Fig. 1).
Discussion
In this work we performed a detailed investigation of the genetic
factors responsible for the relatively low infectivity of the Ag41855
strain for Ae. albopictus and Ae. aegypti mosquitoes. Comprehensive
analyses identified amino acid residues at E2-60 and E2-211 that
modulate the role of the E1-A226V mutation that first arose
during the Indian Ocean epidemic [2,5] on CHIKV infectivity in
these vectors. Individual expression of the E2-G60D or E2-I211T
mutation in the 41855-GFP-226V virus has an identical effect on
the OID50 for Ae. albopictus, and their combined expression
increases infectivity of strain Ag41855, into which the E1-A226V
mutation was introduced, to the level characteristic for strains
LR2006 OPY1 and 37997. However, expression of only E2-G60D
(but not E2-I211T) was necessary and sufficient to elevate the Ae.
albopictus infectivity of the Ag41855 strain with an alanine at E1-
226. When considered together, these data provide new and
important insights into the roles played by E2-G60D and E2-211
mutations in determining CHIKV infectivity for Ae. albopictus
mosquitoes.
The mutation E2-G60D significantly increases Ag41855
infectivity for Ae. albopictus when expressed with either alanine or
valine at E1-226. This indicates that residue E2-60D is important
for vector infectivity of CHIKV, but it does not specifically affect
the previously observed phenotypes reported for the E1-A226V
mutation. This conclusion was further supported by the results
obtained from Ae. aegypti infectivity experiments. In this mosquito,
the E1-A226V mutation does not increase CHIKV infectivity [9]
and therefore this vector can be used as a species-specificity
control. In Ae. aegypti, expression of the E2-60D alone was
necessary and sufficient to increase Ag41855 infectivity to that of
the LR2006 OPY1 and 37997 levels. Interestingly, the E2-60G
residue was found only in three other CHIKV strains, none of
which share close phylogenetic relationships. More importantly,
the IND-00 CHIKV strain, which is almost 100% identical to the
Ag41855 strain based on both nucleotide and amino acid
sequences, has a glutamic acid residue at E2-60. This suggests
that acquisition of E2-D60G occurs sporadically, possibly during
propagation of the virus under laboratory conditions. Altogether,
accumulated data suggests that the E2-60 residue affects some
basic mechanism used by CHIKV to infect its vector. Disruption
of this mechanism exerts a strong inhibitory effect on CHIKV
infectivity to both Ae. albopictus and Ae. aegypti, and therefore this
mutation should be quickly eliminated from naturally transmitted
strains.
To our knowledge, this is the first report incriminating
alphavirus position E2-60 as a major determinant of mosquito
infectivity. Interestingly, a recent study demonstrated that
introduction of two mutations; E2-H55Q and E2-K70E from
the TR339 strain into the TE/5’2J of SINV increased infectivity
for Ae. aegypti, both independently and in combination [30]. These
mutants are located in close proximity to, and share similar
properties with E2-G60D; they both decrease the net positive
charge of the E2 protein, indicating that their mechanism of action
in SINV and CHIKV may be the same. Currently, the particular
role of mutations that increase the charge in this region of the E2
protein is uncertain. Previous studies demonstrated that the E2-
Q55H substitution leads to increased SINV neurovirulence in
mice [40], and also increases binding to neuroblastoma cells.
However, E2-E70K was shown to reduce neurovirulence in
neonatal mice [41]. It would be interesting to investigate possible
association between mutations at E2-60 and the rare neurological
complications and fatalities that were reported for the first time
during the recent chikungunya epidemics [42]. Both mutations
E2-Q55H and E2-E70K were also found to be involved in
increased SINV binding to heparan sulfate (HS) [40,43] which is
in agreement with the hypothesis that the E2-D60G substitution
occurred in the Ag41855 strain as a result of adaptation of the
virus to sulfated proteoglycans abundantly expressed on the cell
surface of BHK-21 and Vero cells. Although, to our knowledge
there are no examples of HS adaptation due to mutations which
lead to loss of a negative charge in E2 protein for any alphaviruses,
it has been shown that E to G mutation at position 122 of the E
protein of Tick-Borne Encephalitis Virus (TBEV) (a member of
family Flaviviridae) mediates adaptation of TBEV to BHK-21 cells
via increasing virus binding to HS [44].
In contrast to the E2-G60D, the mutation E2-I211T signif-
icantly increases infectivity of the Ag41855 strain for Ae. albopictus
only when expressed together with the E1-226V mutation. If
CHIKV has the pre-2005 E1-226A, then the substitution E2-211T
has almost no effect on infectivity for Ae. albopictus compared with
the E2-211I variant. This indicates that the E2-I211T mutation is
responsible for specific modulation of CHIKV infectivity for Ae.
albopictus. The results of CHIKV infectivity for Ae. aegypti further
support this conclusion. In Ae. aegypti, the E1-A226V mutation
does not increase CHIKV infectivity [9] and in the current study,
the E2-I211T mutation did not affect infectivity for these
mosquitoes. Altogether, these mosquito infectivity data indicate
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CHIKV strains possessing E2-211I with respect to transmissibility
by Ae. albopictus. Such viruses would probably not be selected in
nature. This conclusion is in agreement with our phylogenetic
analyses. It has been shown that the E1-A226V mutation
appeared independently at least three times in strains of CHIKV
transmitted by Ae. albopictus [5], but it is important to note that all
of these CHIKV isolates had threonine at position E2-211.
Phylogenetic analysis of the distribution of the E2-211I
mutation revealed substantial differences compared to the E2-
60G mutation. E2-211I was present in the majority of pre-2005
CHIKV isolates in the ECSA complex, suggesting that it might
play an important role for maintenance of CHIKV in the enzootic
African cycle involving wild non-human primates and forest-
dwelling Aedes spp. mosquitoes. Based on isolation frequencies, the
main sylvatic vectors of CHIKV are probably Ae. furcifer-taylori, Ae.
africanus and Ae. luteocephalus [45], with Ae. furcifer-taylori more
important in southern and western Africa [46,47] and Ae. africanus
more important in central regions [45,48,49]. Since the E2-211I
mutation was predominantly found in the CHIKV strains isolated
in central Africa, it is possible that this mutation might give a
selective advantage to CHIKV transmitted by Ae. africanus. The
involvement of the particular species of non-human primates as
vertebrate hosts for CHIKV in central Africa is yet to be analyzed.
We cannot exclude the possibility that the observed predom-
inance of E2-211I among CHIKV strains within the ECSA
complex arose not due to some selective advantage but rather due
to a founder effect. It is possible that the ancestral progenitor of
these viruses had an isoleucine at E2-211 and the absence of the
selective pressure at this position led to fixation of this mutation in
the viral population. It is also possible that CHIKV strains with T
and I at E2-211 coexist in nature, and changes at this position
occur due to some, as of yet unidentified, conditions. In this case,
the apparent prevalence of E2-211I among ECSA strains isolated
before 2005 could be an artifact resulting from the limited
numbers of CHIKV strains available for analysis. This hypothesis
is supported by recent studies of CHIKV evolution on Comoros
and Reunion islands [2,39]. It was shown that the strains of
CHIKV which caused the 2005–2006 outbreak on Reunion were
almost identical to those isolated during the 2005 outbreak on
Comoros island. Two out of three sequenced isolates from
Comoros have E2-211I and one has E2-211T, indicating that
both variants were simultaneously transmitted in the region [39].
Interestingly, Ae. aegypti mosquitoes were the main vector in this
initial epidemic [39], which is consistent with our observation that
the E2-I211T mutation does not affect CHIKV infectivity for this
vector. The precise distribution of E2-211I and E2-211T residues
among early strains (prior to the appearance of the E1-A226V
mutation) from the 2005–2006 outbreak on Reunion is unknown.
However, the presence of only E2-211T in three of three
sequences with the E1-226A [2] circumstantially indicates that
E2-211T was probably the predominant variant on Reunion
Island.
Position E2-211 is located within, or in close proximity to, the
sites that have previously been shown to harbor genetic
determinants of host specificity for several alphaviruses. Substitu-
tion E2-S218N was responsible for increased VEEV subtype IE
infectivity to Ochlerotatus (Aedes) taeniorhynchus mosquitoes [29]. The
deletion of E2-200-220 in SINV significantly decreases infectivity
of the strain MRE16 to Ae. aegypti [27]. Mutations at E2-T213R of
VEEV [50] and E2-T219A of Ross River virus (RRV) [51] were
also shown to be responsible for adaptation of these viruses to a
new host species. It was suggested that this region of the E2 protein
constitutes a cell-receptor binding domain [11] and mutations here
might affect mosquito infectivity by disruption of the proper
interactions of alphavirus with their receptor(s) expressed on
midgut cells [27]. The atomic structure of E2 has not been solved
for any alphavirus, but several lines of evidence indicate that the
regions around position E2-211 are exposed on the virion surface
and are involved in interactions with cellular receptors [11].
Analysis of SINV escape mutants resistant to six neutralizing
monoclonal antibodies (MAb) identified that all changes occurred
between residues 183-216 of the E2 protein, suggesting that this
region constitutes prominent antigenic domain(s) that interact
directly with neutralizing antibodies [52]. In an alternative
approach using lgt11 clones expressing parts of E2, the same
183–216 aa. region was found to interact with five MAbs reactive
to E2 protein [53]. Anti-idiotypic antibodies produced to one of
the MAbs (MAb49) which was used by [52,53] blocked SINV
binding by up to 50% and were capable of immunoprecipitating a
63 kD protein from chicken cell’s plasma membranes. Interest-
ingly the SINV escape mutant for MAb49 has a single aa.
substitution E2-R214P [54]. Cryoelectron microscopy of RRV
complexed with the Fab fragment of MAb T10C9, which binds in
the vicinity of the E2-216 residue, revealed that the binding region
is located at the outermost tip of the E2 glycoprotein [55].
Cryoelectron microscopy followed by image reconstruction of HS-
adapted RRV revealed that HS binds in the same outermost
region of the E2 glycoprotein as MAb T10C9 [56]. The E2-
N218K mutation, which was responsible for adaptation of RRV to
HS binding, was also responsible for resistance of the virus to
neutralization by MAb T10C9 [57]. Interestingly the E2-N218K
mutation was originally selected for replication of RRV in chicken
embryo fibroblast cells and was shown to attenuate the virus in 1-
day old mice [58]. This demonstrates that changes in this region of
the E2 glycoprotein expand the host range of RRV in cell culture
by allowing virus to interact with cell surface HS moieties.
Considering the evidence for the involvement of mutations in the
region around position E2-211 in receptor binding and in
adaptation to new host species, we believe that the simplest
explanation for the specific effects of the E2-211I mutation on
CHIKV infectivity for Ae. albopictus mosquitoes is that this
substitution disrupts the ability of CHIKV to interact with a
particular receptor on the midgut epithelial cells of Ae. albopictus.
This receptor might be responsible for targeting of CHIKV to the
specific endosomal compartments/domains with a unique lipid
composition that favors fusion of CHIKV possessing valine at E1-
226, as compared to alanine. If this pathway is blocked by the E2-
211I mutation then CHIKV may infect Ae. albopictus mosquitoes
using an alternative receptor(s) that targets virus into different
endosomes, in which the presence of the E1-A226V does not result
in differential infectivity. It is also tempting to suggest that, in Ae.
aegypti mosquitoes, only the second (alternative) pathway is available
for CHIKV infection, thereby making this species insensitive to the
E1-A226V mutation. In agreement with this hypothesis is the fact
that mutations at position E1-226 could be responsible for
modulation of the lipid requirement for growth of CHIKV [9],
Semliki Forest virus [59] and SINV [60] in C6/36 cells.
Alternatively, mutations at E2-211 might affect the stability of
the E2-E1 heterodimers, which would differentially affect fusion
properties of the CHIKV with E1-226A or E1-226V. It has been
shown that the mutation E2-D216G can rescue a PE2 cleavage
mutant of SINV by disrupting the E2-E1 heterodimer stability
under acidic condition [61]. However, there were no significant
differences in the pH threshold for membrane fusion or cholesterol
dependence of CHIKV containing E2-211T or E2-211I (data not
shown). These data indicate that that these mutations probably
affect steps in CHIKV cells entry preceding fusion.
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molecular mechanisms responsible for the observed, unique roles
of the substitutions at position E2-60 and E2-211 of CHIKV. The
widespread and increasing distribution of Ae. albopictus [13,14]
represents a potential threat with respect to the spread and
establishment of CHIKV in other tropical and temperate regions.
The current study builds upon our previous work and reveals that
mosquito species-specificity of CHIKV, and potentially of other
important human and animal pathogens, for example VEEV, can
be influenced by multiple genes that can act synergistically.
Understanding the complex virus-vector interactions and their
underlying mechanisms is critical to enhance our capacity to assess
the risks of epidemic emergence. Furthermore, understanding
these interactions may also reveal targets that can be exploited for
the design of antiviral strategies to modify viral infectivity/
attenuation and identify cellular molecules and pathways involved
in the infection process.
Materials and Methods
Viruses and plasmids
The plasmid encoding eGFP-expressing full-length cDNA clone
derived from CHIKV LR2006 OPY1 strain LR-GFP-226V
(CHIK-LR 5’GFP, accession number EU224269) has been
previously described [9,32]. The plasmids encoding full-length
and full-length eGFP-expressing i.c. of the Ag41855 strain of
CHIKV were generated using methodology similar to those
described previously for CHIKV strains LR2006 OPY1 and
37997 [32,33]. The Ag41855 strain of CHIKV was obtained from
the World Reference Center for Emerging Viruses and Arbovi-
ruses at the University of Texas Medical Branch, Galveston, TX.
This strain was isolated in 1982 in Uganda from a human and was
passed tree times in suckling mice and twice in Vero cells before
being used for i.c. construction. The Ag41855 strain of CHIKV
was chosen because of its close phylogenetic relationship to the
strains implicated in the 2006–2007 epidemics, and therefore
represented an interesting model for studying the evolutionary
events that preceded these epidemics.
All plasmids were constructed and propagated using conven-
tional cloning methods [62]. The integrity of PCR-generated
cDNAs was verified by sequence analysis. All plasmids were
purified by either centrifugation in cesium chloride gradients or by
using QIAGEN Plasmid Mini Kits (QIAGEN, Valencia, CA)
following the manufacturer’s instructions. Plasmid maps, sequenc-
es and detailed descriptions of all constructs are available from the
authors upon request.
AllplasmidswerelinearizedwithNotIan dinvitrotranscribedfrom
the minimal SP6 promoter using the mMESSAGE mMACHINE
kit (Ambion, Austin, Texas) following the manufacturer’s instruc-
tions. The yield and integrity of synthesized RNA were analyzed by
agarose gel electrophoresis in the presence of 0.25 mg/ml of
ethidium bromide. RNA (,10 mg) was electroporated into 1610
7
BHK-21 (baby hamster kidney) cells as previously described and
cells were then transferred to 75 cm
2 tissue culture flasks with 15 ml
of Leibovitz L-15 (L-15) medium. Supernatants were collected at 24
and 48 h post-electroporation and stored at 280uC. Electropora-
tion efficiency was estimated using an infectious centers assay as
previously described [32]. Briefly, 1610
5 electroporated BHK-21
cells were serially 10-fold diluted and seeded in six-well plates
containing 10
6 Vero (green monkey kidney) cells per well in MEM
media. Following an incubation for 2 h at 37uC, cells were overlaid
with 2 mL of 0.5% agarose containing MEM supplemented with
3.3% FBS. Cells were incubated for 2 d at 37uC until plaques
developed and were stained with crystal violet.
Cells and mosquitoes
BHK-21 cells were maintained at 37uC in L-15 medium
supplemented with 10% fetal bovine serum (FBS), 100 U
penicillin, and 100 mg/ml streptomycin. Ae. aegypti (white-eyed
Higgs variant of the Rexville D strain) and Ae. albopictus (Galveston
strain) were reared at 27uC and 80% relative humidity under a
16 h light: 8 h dark photoperiod, as previously described [33].
Adults were kept in paper cartons supplied with 10% sucrose on
cotton balls. To promote egg production, females were fed on
anaesthetized hamsters once per week. All animal manipulations
were performed in accordance with National Institutes of Health
and University of Texas Medical Branch Institutional Animal
Care and Use Committee (http://research.utmb.edu/iacuc/)
approved protocols.
Viral titers from tissue culture supernatants were determined by
titration on Vero cells and expressed as tissue culture infectious
dose 50 percent endpoint titers (Log10TCID50/ml) as previously
described [63].
Oral infection of mosquitoes
Most of the studies of oral infectivity of CHIKV in Ae. aegypti
and Ae. albopictus mosquitoes were performed using eGFP-
expressing viruses. Ae. aegypti and Ae. albopictus were infected in
an Arthropod Containment Level 3 insectary as described
previously [64,65]. To estimate the Oral Infectious Dose 50%
values (OID50), frozen stocks of viruses were thawed at 37uC and
four to five 10-fold serial dilutions of virus were made in L-15
medium followed by mixing the samples with an equal volume of
defibrinated sheep blood. Each viral dilution was presented to 50
4–5-day post-eclosion Ae. aegypti or Ae. albopictus female mosquitoes
(starved for 24 h) using a Hemotek membrane feeding system
(Discovery Workshops, Accrington, Lancashire, United Kingdom)
fitted with a murine skin membrane. Mosquitoes were permitted
to feed for 1 h, after which engorged mosquitoes [stage.3b [66]]
returned to the cages for maintenance.
At 7 days post-infection (dpi) mosquitoes were dissected and
eGFP expression in infected midguts was analyzed by fluorescence
microscopy. A mosquito was considered infected if at least one
focus of eGFP-expressing cells was present in the midgut. To
compare oral infectivity of non-eGFP-expressing viruses 16 to 24
mosquitoes from each viral dilution were collected on day 7 post-
infection, individually triturated in 1 ml of L-15 media and titrated
as described [33]. A mosquito was considered infected if it
contained more than 0.94 Log10TCID50 infection units (limit of
detection). The experiments were performed once or twice for
each virus. OID50 values and confidence intervals were calculated
using PriProbit program (version 1.63). The SAS equivalent
method was used to calculate the fiducial limits (confidence
intervals), assuming normal function distribution and an ‘‘all or
nothing’’ response parameter. The difference between two OID50
values was considered statistically significant if 95% fiducial limits
did not overlap.
Phylogenetic analyses
Entire E2-K6-E1 genome region of the selected CHIKV strains
were sequenced or obtained from GenBank. Viruses whose
genomes were not available in GenBank were obtained from the
World Reference Center for Emerging Viruses and Arboviruses at
the University of Texas Medical Branch, Galveston, TX. Viruses
were passaged in C6/36 Ae. albopictus cells, concentrated using
polyethylene glycol (7% W/V) and NaCl (2.3% (W/V), and RNA
was extracted using TRIzol (Invitrogen, Carlsbad, CA) according
to the manufacturer’s protocol. Overlapping PCR amplicons were
amplified from viral RNA using the Titan One Tube RT-PCR
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turer’s protocol. Primer sequences and specific PCR protocols are
available from the authors upon request. Agarose gel-purified
amplicons were sequenced directly using BigDye Terminator v3.1
cycle sequencing kit (Applied Biosystems, Foster City, CA; primer
sequences available upon request) designed from a genomic
alignment of strains 37997, LR2006 OPY1, 15561, TSI-GSD-
218, Ross, and RSU1 sequence. Sequencing was performed in an
ABI PRISM model 3100 Genetic Analyzer (Applied Biosystems,
Foster City, CA), and sequences were edited and assembled in
VectorNTI v10.3 (Invitrogen, www.invitrogen.com). Newly-gen-
erated CHIKV sequences as well as those available from the
GenBank library, along with that of o’nyong-nyong virus (ONNV,
strain Gulu, used as an outgroup) were aligned with ClustalW in
MacVector v9.0 (MacVector, Inc., Cary, NC) or BioEdit v7.0.5.3
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html); gap introduc-
tions in the nucleotide alignment were refined using amino acid
alignments to preserve codon homology. The phylogeny was
produced using neighbor-joining and maximum parsimony
methods available in the PAUP* v4.0b 10 package (Sinauer
Associates, Inc., Sunderland, MA). Bootstrap analysis [37] was
performed with 1000 replicates to assess reliability of the grouping.
Supporting Information
Figure S1 Schematic representation of the viruses used in this
study.
Found at: doi:10.1371/journal.pone.0006835.s001 (1.20 MB TIF)
Table S1 Recovery of the viruses with mutations in E2 protein
after electroporation of in vitro transcribed RNA. a - amino acids
at position of E1-226. b - amino acids at position of E2: 60, 162,
211. c - Specific infectivity of in vitro transcribed RNA. 10(7)
BHK-21 cells were transfected with 10 mg of RNA. Electroporated
BHK-21 cells were ten fold serially diluted, seeded in 6 well tissue
culture plates containing 1610(6) Vero cells per well in MEM
media. Following an incubation for 2 h at 37uC, cells were
overlaid with 2 mL of 0.5% agarose containing 3.3% FBS in
MEM. Plaques were scored and measured on day 2 post
transfection. d - Supernatants of electroporated BHK-21 cells
were collected on days 1 and 2. Virus titers were determined by
titration on Vero cells and expressed as Log10TCID50/ml. e -
Plaque size of infectious centers expressed in millimeters6standard
deviation. h - hours post-infection. Blue color corresponds to
authentic amino acids at indicated positions of strain Ag41855, red
color corresponds to authentic amino acids at indicated positions
of strain LR2006 OPY1.
Found at: doi:10.1371/journal.pone.0006835.s002 (0.06 MB
DOC)
Table S2 Summary of virus strains used in phylogenetic analysis.
Genotype: ECSA - Eastern/Central/South African; W. Afr - West
African. Passage history: SM: suckling mouse; C6/36: Ae.
albopictus cell line; Vero: African green monkey cell line; RMK:
Rhesus monkey kidney cell line; MRC-5: human lung epithelium;
AP61: Ae. pseudoscutellaris cell line. GenBank Acc - GenBank
accession number. ? - information is unavailable to the authors
Found at: doi:10.1371/journal.pone.0006835.s003 (0.10 MB
DOC)
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